Bruker Corp. Aktie
35,48 €
Deine Einschätzung
Bruker Corp. Aktie
Was spricht für und gegen Bruker Corp. in den nächsten Jahren?
Pro
Kontra
Rendite von Bruker Corp. im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Bruker Corp. | 2,44 % | -5,03 % | -21,28 % | -34,20 % | -13,02 % | - | - |
| Healthequity Inc. | 0,00 % | -7,64 % | -18,40 % | -37,85 % | -14,74 % | 20,91 % | -5,67 % |
| Omnicell Inc. | -16,41 % | -20,10 % | -18,50 % | -23,11 % | -15,98 % | -37,90 % | -68,95 % |
| Myriad Genetics | -0,47 % | -8,94 % | -22,88 % | -65,20 % | -19,25 % | -76,12 % | -82,03 % |
Kommentare
News
Why a $30 Million Bruker Stock Trim Matters Amid an 18% Slide
Utah-based Grandeur Peak Global Advisors reduced its stake in Bruker Corporation (NASDAQ:BRKR) by 709,697 shares in the third quarter, contributing to a net position change of $29.54 million
Why Bruker Stock Slumped Monday
Bruker (NASDAQ: BRKR) published its latest quarterly earnings report Monday morning, and despite notching a double beat the company's stock took something of a hit. Its price fell nearly 1% by the
Why This Investment Advisor Sold Off Its $3.6 Million Bruker Stake
On Tuesday, Massachusetts-based Lane Generational disclosed that it sold out of Bruker (NASDAQ:BRKR), liquidating 87,607 shares for an estimated $3.6 million in the third quarter.
According to a




